Veritas Medicine Release: OvaRex MAb For Patients With Advanced Ovarian Cancer May Extend Remission Following Favorable Surgery And Chemotherapy 
10/19/2005 5:12:40 PM

LOS ANGELES--(BUSINESS WIRE)--Feb. 10, 2005-- Los Angeles-area Researchers Seeking New Standard of Care for Advanced Ovarian Cancer For the majority of patients with advanced ovarian cancer, the current standard of care and front-line treatments - surgery and chemotherapy - are not enough to control the high recurrence rate. Researchers at several clinical centers in the